NTHL1 tumor syndrome, also known in the literature as NTHL1-associated polyposis, is a multi-tumor spectrum disease, whose narrow spectrum is mostly characterized by an increased lifetime risk for colorectal polyposis, colorectal cancer (CRC), and breast cancer (BC) (Kuiper et al., 2020). This evidence concerns the gene NTHL1 and breast carcinoma.